by Helena Cowley | Dec 19, 2019 | News
Proceeds with Development of Lead Candidate to Address Unmet Need in Kidney Disease Gainesville, Fla. (December 19, 2019) – Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for secondary hyperoxaluria,...